ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,440,967 | +127.7% | 2,931 | +80.5% | 0.00% | +100.0% |
| Q2 2023 | $632,921 | -11.1% | 1,624 | -15.0% | 0.00% | 0.0% |
| Q1 2023 | $712,001 | +12.0% | 1,911 | +13.9% | 0.00% | 0.0% |
| Q4 2022 | $635,677 | -25.7% | 1,678 | -30.8% | 0.00% | -50.0% |
| Q3 2022 | $856,000 | -2.1% | 2,425 | +5.3% | 0.00% | 0.0% |
| Q2 2022 | $874,000 | +54.4% | 2,304 | +28.1% | 0.00% | +100.0% |
| Q1 2022 | $566,000 | +28.3% | 1,798 | +43.0% | 0.00% | 0.0% |
| Q4 2021 | $441,000 | +3.0% | 1,257 | -11.5% | 0.00% | 0.0% |
| Q3 2021 | $428,000 | +21.9% | 1,420 | +21.8% | 0.00% | 0.0% |
| Q2 2021 | $351,000 | +13.6% | 1,166 | +3.6% | 0.00% | 0.0% |
| Q1 2021 | $309,000 | +3.3% | 1,125 | +10.7% | 0.00% | 0.0% |
| Q4 2020 | $299,000 | +95.4% | 1,016 | +74.6% | 0.00% | – |
| Q3 2020 | $153,000 | +40.4% | 582 | +19.5% | 0.00% | – |
| Q2 2020 | $109,000 | +73.0% | 487 | +1.9% | 0.00% | – |
| Q1 2020 | $63,000 | -6.0% | 478 | +15.2% | 0.00% | – |
| Q4 2019 | $67,000 | +3250.0% | 415 | +3092.3% | 0.00% | – |
| Q2 2019 | $2,000 | -92.6% | 13 | -94.1% | 0.00% | – |
| Q1 2019 | $27,000 | +35.0% | 219 | +3.8% | 0.00% | – |
| Q4 2018 | $20,000 | -50.0% | 211 | -60.5% | 0.00% | – |
| Q3 2018 | $40,000 | -28.6% | 534 | -20.5% | 0.00% | – |
| Q2 2018 | $56,000 | -90.6% | 672 | -91.0% | 0.00% | -100.0% |
| Q1 2018 | $598,000 | – | 7,436 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |